Published • loading... • Updated
Nuplazid (pimavanserin) for Parkinson’s disease | Parkinson's News...
Summary by Parkinson's News Today
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Nuplazid (pimavanserin) for Parkinson’s disease | Parkinson's News...
What is Nuplazid for Parkinson’s disease? Nuplazid (pimavanserin) is an oral medication approved to treat hallucinations and delusions in people with psychosis related to Parkinson’s disease. Parkinson’s disease psychosis — when a person has trouble distinguishing what is real from what isn’t — is one of the possible nonmotor symptoms of the neurodegenerative disease. It is most commonly marked by hallucinations — seeing, hearing, or sensing thi…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
